Technology: Development Summary

ALGENEX has proprietary platform technologies to improve recombinant protein production and vaccines efficacy, as well as well differentiated products in the field of vaccines, diagnostic and therapeutic molecules.

ALGENEX has proprietary platform technologies to improve recombinant protein production and vaccines efficacy, as well as well differentiated products in the field of vaccines, diagnostic and therapeutic molecules.

. 

Copyright © 2010 Alternative Gene Expression S.L. (ALGENEX) . All rights reserved. Terms and Conditions
Centro empresarial - Parque Científico y Tecnológico de la Universidad Politécnica de Madrid - Campus de Montegancedo – 28223.Pozuelo de Alarcón - Madrid – Spain.
Phone: +34 91 452 49 41/42 - Fax: +34 91 347 87 71 - info@algenex.es